As shown in Fig. 6D, Lcn-2 levels in patients with colorectal cancer were significantly higher compared with those in healthy individuals (controls: 7.8 ± 1.0 vs. colorectal cancer: 16.3 3.4 ng/mg feces, P < 0.036). This evidence concerns the gene LCN2 and colorectal cancer.